Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
Translational, interdisciplinary research projects in the field of Personalised Medicine which encourage collaboration between academia, clinical/public health research, SMEs as well as policy makers, regulatory/HTA agencies and patient organisations. |
Característiques principals
With its fifth transnational call (non-cofunded by the EC), ERA PerMed aims to foster research in prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels: i. preventive measures decreasing the rate of incidence (primary prevention), ii. early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and iii. interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention). Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated. |
Lloc de presentació
IMIM and PSMAR staff who need more information should contact:: Competitive Funding. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: cbarnwell@imim.es Ext.: 1670 Marta López: mlopez4@imim.es Ext.: 1576 |
Convocatòria (URL)
https://erapermed.isciii.es/joint-calls/joint-transnational-call-2022/ Submission of proposals is mandatory on: https://ptoutline.eu/app/erapermed2022 |
Informació addicional
If you are looking for potential partners, please have a look also at the ICPerMed Partnering Tool: https://partnering.pt-dlr.de/ICPerMed |
Requisits
Eligibility Criteria: For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members. Please contact Competitive Funding of you intend to apply for this call, in order to confirm your eligibility and the different funding entities you can apply to. |
Dotació
For Spanish participants: Between €150,000 to € €250,000 depending on the role and funding entity. Please see the Guidelines for further information. |
Durada
3 years |
AVÍS IMPORTANT
The submission of proposals follows a two-stage procedure: Spanish partners applying for funding through ISCIII and FCAECC must submit in addition the form: “Additional application form for Spanish applicants applying for funding from ISCIII/FCAECC” |
AVÍS IMPORTANT
ERA PerMed updated the Guidelines for Applicants and the Call text on December 15th. You can download the final documents at the end of this page. |
Arxius
Arxiu |
---|
5_ERA-PerMed_JTC2022_Pre-Proposal_form.docx |
Annex-3_ERA-PerMed-JTC2022-ISCIII-FCAECC.docx |
1_ERA-PerMed_2022_Call_text_final.docx.pdf |
2_ERA-PerMed_JTC2022_Guidelines_final-V1.pdf |